Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

K Fischer; O Al-Sawaf; J Bahlo; A M Fink; M Tandon; M Dixon; Ton Langerak; M Mobasher; M Hallek

doi:10.1056/NEJMoa1815281

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

K Fischer, O Al-Sawaf, J Bahlo, A M Fink, M Tandon, M Dixon, Ton Langerak, M Mobasher, M Hallek

Immunology

Research output: Contribution to journal › Article › Academic › peer-review

686 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2225-2236
Number of pages	12
Journal	New England Journal of Medicine
Volume	380
Issue number	23
DOIs	https://doi.org/10.1056/NEJMoa1815281
Publication status	Published - 2019

Research programs

EMC MM-02-72-01

Access to Document

10.1056/NEJMoa1815281

Cite this

@article{c6ed4f0856f64380b8cdeaf857cf6cbf,

title = "Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions",

author = "K Fischer and O Al-Sawaf and J Bahlo and Fink, {A M} and M Tandon and M Dixon and Ton Langerak and M Mobasher and M Hallek",

year = "2019",

doi = "10.1056/NEJMoa1815281",

language = "Undefined/Unknown",

volume = "380",

pages = "2225--2236",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "23",

}

TY - JOUR

T1 - Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

AU - Fischer, K

AU - Al-Sawaf, O

AU - Bahlo, J

AU - Fink, A M

AU - Tandon, M

AU - Dixon, M

AU - Langerak, Ton

AU - Mobasher, M

AU - Hallek, M

PY - 2019

Y1 - 2019

U2 - 10.1056/NEJMoa1815281

DO - 10.1056/NEJMoa1815281

M3 - Article

C2 - 31166681

SN - 0028-4793

VL - 380

SP - 2225

EP - 2236

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 23

ER -